BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 18219319)

  • 1. Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans.
    Linke K; Mace PD; Smith CA; Vaux DL; Silke J; Day CL
    Cell Death Differ; 2008 May; 15(5):841-8. PubMed ID: 18219319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A site-directed mutagenesis study of the MdmX RING domain.
    Egorova O; Mis M; Sheng Y
    Biochem Biophys Res Commun; 2014 May; 447(4):696-701. PubMed ID: 24755078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of Mdm2 C-terminal tail suggests an evolutionarily conserved role of its length in Mdm2 activity toward p53 and indicates structural differences between Mdm2 homodimers and Mdm2/MdmX heterodimers.
    Dolezelova P; Cetkovska K; Vousden KH; Uldrijan S
    Cell Cycle; 2012 Mar; 11(5):953-62. PubMed ID: 22333590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
    Ghosh M; Huang K; Berberich SJ
    Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53.
    Kostic M; Matt T; Martinez-Yamout MA; Dyson HJ; Wright PE
    J Mol Biol; 2006 Oct; 363(2):433-50. PubMed ID: 16965791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mdm2 and MdmX RING Domains Play Distinct Roles in the Regulation of p53 Responses: A Comparative Study of Mdm2 and MdmX RING Domains in U2OS Cells.
    Egorova O; Lau HH; McGraphery K; Sheng Y
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An essential function of the extreme C-terminus of MDM2 can be provided by MDMX.
    Uldrijan S; Pannekoek WJ; Vousden KH
    EMBO J; 2007 Jan; 26(1):102-12. PubMed ID: 17159902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDMX Recruits UbcH5c to Facilitate MDM2 E3 Ligase Activity and Subsequent p53 Degradation
    Yang J; Jin A; Han J; Chen X; Zheng J; Zhang Y
    Cancer Res; 2021 Feb; 81(4):898-909. PubMed ID: 33277368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role for a central part of Mdm2 in the ubiquitylation of p53.
    Meulmeester E; Frenk R; Stad R; de Graaf P; Marine JC; Vousden KH; Jochemsen AG
    Mol Cell Biol; 2003 Jul; 23(14):4929-38. PubMed ID: 12832478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Single Conserved Amino Acid Residue as a Critical Context-Specific Determinant of the Differential Ability of Mdm2 and MdmX RING Domains to Dimerize.
    Kosztyu P; Slaninová I; Valčíková B; Verlande A; Müller P; Paleček JJ; Uldrijan S
    Front Physiol; 2019; 10():390. PubMed ID: 31024344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RING domain-mediated interaction is a requirement for MDM2's E3 ligase activity.
    Kawai H; Lopez-Pajares V; Kim MM; Wiederschain D; Yuan ZM
    Cancer Res; 2007 Jul; 67(13):6026-30. PubMed ID: 17616658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 regulation: teamwork between RING domains of Mdm2 and MdmX.
    Wang X
    Cell Cycle; 2011 Dec; 10(24):4225-9. PubMed ID: 22134240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting RING domains of Mdm2-MdmX E3 complex activates apoptotic arm of the p53 pathway in leukemia/lymphoma cells.
    Wu W; Xu C; Ling X; Fan C; Buckley BP; Chernov MV; Ellis L; Li F; Muñoz IG; Wang X
    Cell Death Dis; 2015 Dec; 6(12):e2035. PubMed ID: 26720344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Catalytic Active but Non-Aggregating MDM2 RING Domain Variant.
    Magnussen HM; Huang DT
    J Mol Biol; 2021 Mar; 433(5):166807. PubMed ID: 33450248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Turning the RING domain protein MdmX into an active ubiquitin-protein ligase.
    Iyappan S; Wollscheid HP; Rojas-Fernandez A; Marquardt A; Tang HC; Singh RK; Scheffner M
    J Biol Chem; 2010 Oct; 285(43):33065-33072. PubMed ID: 20705607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hetero-oligomerization with MdmX rescues the ubiquitin/Nedd8 ligase activity of RING finger mutants of Mdm2.
    Singh RK; Iyappan S; Scheffner M
    J Biol Chem; 2007 Apr; 282(15):10901-7. PubMed ID: 17301054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MDM2 RING domain and central acidic domain play distinct roles in MDM2 protein homodimerization and MDM2-MDMX protein heterodimerization.
    Leslie PL; Ke H; Zhang Y
    J Biol Chem; 2015 May; 290(20):12941-50. PubMed ID: 25809483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMX is essential for the regulation of p53 protein levels in the absence of a functional MDM2 C-terminal tail.
    Sanford JD; Yang J; Han J; Tollini LA; Jin A; Zhang Y
    BMC Mol Cell Biol; 2021 Sep; 22(1):46. PubMed ID: 34551723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity.
    Nomura K; Klejnot M; Kowalczyk D; Hock AK; Sibbet GJ; Vousden KH; Huang DT
    Nat Struct Mol Biol; 2017 Jul; 24(7):578-587. PubMed ID: 28553961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis and consequences of Mdm2 E3 ligase inhibition in human tumor cells.
    Wade M; Li YC; Matani AS; Braun SM; Milanesi F; Rodewald LW; Wahl GM
    Oncogene; 2012 Nov; 31(45):4789-97. PubMed ID: 22266850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.